Monkeypox virus antigens — Drug Target

All drugs that target Monkeypox virus antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Live attenuated viral vaccine

Phase 3 pipeline (1)

• MVA-BN standard regimen · Jean-Pierre Van geertruyden · Live attenuated viral vaccine · Immunology / Infectious Disease
  MVA-BN is a live attenuated vaccinia virus-based vaccine that stimulates immune responses against monkeypox virus antigens.